MIRA Pharmaceuticals Progresses MIRA-55 and SKNY-1 Toward IND-Enabling Studies

MIRA-55SKNY-1Positive

AI Analysis

Summary

MIRA Pharmaceuticals announced progress on its MIRA-55 and SKNY-1 programs toward IND-enabling studies. The announcement indicates advancement in preclinical development activities.

Outcome Details

Programs progressing toward IND-enabling studies

Importance:5/10

Sentiment:

0.30

MIRA Pharmaceuticalsdrug developmentIND-enabling studiesMIRA-55SKNY-1

Related Companies

$MIRA

Read the original article

Published by yahoo_finance on July 30, 2026 12:00 PM

Read Original